(Reuters) – The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.
Source: Reuters Medical News
| While the MPS seems to think so, Hannah Travis at Bolt Burdon Kemp looks at the implications
Related items from OnMedica RCGP raises concerns over Bawa-Garba case |
Source: OnMedica